Trial Information

Summary: Essential Tremor

A Phase II Clinical Research Trial for essential tremor. This is a double blind, placebo-controlled, crossover study, in which all patients will receive investigational medication. Medication, physical exams and laboratory evaluation are free of charge to the patient. There is financial compensation upon qualification at the conclusion of the study.

We are looking for individuals who:

• Are male or female between the ages of 18 and 85 years of age
• Experience shaking in both hands or whose arms shake when trying to eat, drink, or reach for something
• Experience shaky handwriting due to the tremor
• Experience tremor that disappears when at rest, like lying in bed
• Have experienced tremor for 5 or more years.

Patient Exclusion Criteria:

• No other abnormal neurological signs or conditions other than essential tremor, that could interfere with the evaluation of tremor, such as Parkinson's disease, stroke, dystonia, etc.
• No serious or life-threatening medical illnesses within the past year.
• No history of significant cardiac disease including, congenital QT shortening, unstable angina, heart failure or myocardial infarction.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.